Abstract
The increasing incidence of hepatocellular carcinoma (HCC) is becoming a considerable problem in the UK and worldwide. Although there is no national surveillance programme, increasing evidence shows that surveillance programmes may be beneficial and potentially cost-effective. Small, non-symptomatic HCCs that could be detected on regular ultrasound screening are amenable to treatment, including liver transplantation, surgical resection and radio frequency ablation with good 5-year survival rates. However, large tumours, greater than 5 cm, have a poor prognosis and treatment is only palliative. Therefore, the identification of small lesions through a formalized liver ultrasound surveillance programme together with serum alpha-fetoprotein (AFP) may be useful.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
